We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Immunoassay Developed for Rapid Leptospirosis Diagnosis

By LabMedica International staff writers
Posted on 13 Nov 2012
A rapid assay has been developed using immunodominant Leptospira immunoglobulin-like proteins in a Dual Path Platform (DPP) for the diagnosis of leptospirosis.

The rapid point-of-care immunoassay was evaluated for accuracy in diagnostic performance and compared with the microscopic agglutination test (MAT), in an urban setting.

Scientists at Duke University School of Medicine (Durham, NC, USA) and their collaborators measured the sensitivity of the assay using 446 serum samples from 378 individuals with either mild or severe leptospirosis from two urban Brazilian populations. Control sera, including healthy blood donors, dengue cases, and patients with confirmed syphilis were also tested.

The DPP assay for leptospirosis was developed by Chembio Diagnostic Systems (Medford, NY, USA) and is manufactured by Bio-Manguinhos (Rio de Janeiro, Brazil). The sera assayed by the DPP were also tested by an immunoglobulin M enzyme-linked immunosorbent assay (IgM- ELISA) and the MAT. Three independent operators visually interpreted results of the DPP after 20 minutes as either positive or negative.

The overall sensitivity for paired sera was 100% for severe and 73% for mild disease. In the acute phase of the infection, the assay achieved a sensitivity of 85% for severe and 64% for mild leptospirosis. Within seven days of illness onset, the assay achieved a sensitivity of 77% for severe disease and 60% for mild leptospirosis. Sensitivity of the DPP assay was similar to that for IgM-ELISA and increased with both duration of symptoms.

The authors concluded that the DPP assay performed acceptably well for diagnosis of severe acute clinical leptospirosis and can be easily implemented in hospitals and health posts where leptospirosis is a major public health problem. However, test accuracy may need improvement for mild disease and early stage leptospirosis, particularly in regions with high transmission. The study was published on November 1, 2012, in the journal Public Library of Science Neglected Tropical Diseases (PLoSNTD).

Related Links:

Duke University School of Medicine
Chembio Diagnostic Systems
Bio-Manguinhos



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HPV Test
Allplex HPV28 Detection
New
Multi-Chamber Washer-Disinfector
WD 390

Latest Microbiology News

New Bacterial Target Identified for Early Detection of Noma
13 Nov 2012  |   Microbiology

Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections
13 Nov 2012  |   Microbiology

Rapid Urine Test Speeds Antibiotic Selection for UTIs
13 Nov 2012  |   Microbiology